1 / 5

Antisense and RNAi Therapeutics Market Expected to Witness Robust Growth

The Antisense & RNAi Therapeutics global market report analyzes market by Technology (Antisense RNA, RNA Interference), by Route of Administration (Intrathecal, Intravenous, Subcutaneous, Others), by Application (Neurodegenerative Disorders, Oncology, Cardiometabolic & Renal Disorders, Genetic Disorders, Infectious Diseases, Respiratory Disorders, Other Applications), and by geographic region (North America, Europe, Asia-Pacific, South America and Middle East & Africa for 2021-2030 period in terms of value in US$ million, projected from 2024 through 2030.

industryexperts
Download Presentation

Antisense and RNAi Therapeutics Market Expected to Witness Robust Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ANTISENSE AND RNAI THERAPEUTICS MARKET EXPECTED TO WITNESS ROBUST GROWTH, OWING TO FOCUSED R&D IN RARE DISEASES LIKE ATTR AMYLOIDOSIS AND SMA

  2. A new report from Industry Experts, Inc. on "Antisense and RNAi Therapeutics Market", discloses that the global market for Antisense and RNAi Therapeutics is estimated at US$5.4 billion in 2024 and is anticipated to post a CAGR of 17.8% during the 2024-2030 analysis period and stand at a projected US$14.4 billion by 2030.

  3. Antisense and RNAi Therapeutics market is analyzed in this report globally, covering the major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.

  4. The global market for Antisense and RNAi Therapeutics studied in this report with respect to Technology – Antisense RNA and RNA Interference; Route of Administration – Intrathecal, Intravenous, Subcutaneous and Others (Including Topical, Pulmonary, Transdermal, Oral, and Ophthalmic Administration); and Application – Neurodegenerative Disorders, Oncology, Cardiometabolic & Renal Disorders, Genetic Disorders, Infectious Diseases, Respiratory Disorders and Other Applications (Including Ocular, Muscle, Skin, Autoimmune, Hematological Disorders, and Others).

  5. ABOUT INDUSTRY EXPERTS, INC. Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/

More Related